These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor. Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346 [TBL] [Abstract][Full Text] [Related]
9. Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D Bonifazi A; Yano H; Ellenberger MP; Muller L; Kumar V; Zou MF; Cai NS; Guerrero AM; Woods AS; Shi L; Newman AH J Med Chem; 2017 Apr; 60(7):2890-2907. PubMed ID: 28300398 [TBL] [Abstract][Full Text] [Related]
10. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic-Like Efficacy of Dopamine D Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351 [TBL] [Abstract][Full Text] [Related]
12. Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. Wenk D; Khan S; Ignatchenko V; Hübner H; Gmeiner P; Weikert D; Pischetsrieder M; Kislinger T J Proteome Res; 2023 Jan; 22(1):259-271. PubMed ID: 36508580 [TBL] [Abstract][Full Text] [Related]
13. Molecular determinants of biased agonism at the dopamine D₂ receptor. Weichert D; Banerjee A; Hiller C; Kling RC; Hübner H; Gmeiner P J Med Chem; 2015 Mar; 58(6):2703-17. PubMed ID: 25734236 [TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor. Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247 [TBL] [Abstract][Full Text] [Related]
17. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation. Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132 [TBL] [Abstract][Full Text] [Related]
18. Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. Adhikari P; Xie B; Semeano A; Bonifazi A; Battiti FO; Newman AH; Yano H; Shi L Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924613 [TBL] [Abstract][Full Text] [Related]
19. Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions. Rose SJ; Pack TF; Peterson SM; Payne K; Borrelli E; Caron MG Neuropsychopharmacology; 2018 Apr; 43(5):1164-1173. PubMed ID: 29068002 [TBL] [Abstract][Full Text] [Related]
20. Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D Chun LS; Vekariya RH; Free RB; Li Y; Lin DT; Su P; Liu F; Namkung Y; Laporte SA; Moritz AE; Aubé J; Frankowski KJ; Sibley DR Front Synaptic Neurosci; 2018; 10():2. PubMed ID: 29515433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]